{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:27:20Z","timestamp":1788413240136,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013506","name":"Kuopion Seudun Hengityss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008309","name":"Hengityssairauksien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recognition of disorder phenotypes may help to estimate prognosis and to guide the clinical management. Current cough management guidelines classify patients according to the duration of the cough episode. However, this classification is not based on phenotype analyses. The present study aimed to identify cough phenotypes by clustering.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An email survey among employed, working-age subjects identified 975 patients with current cough. All filled in a comprehensive 80-item questionnaire including the Leicester Cough Questionnaire. Phenotypes were identified utilizing K-means partitional clustering. A subgroup filled in a follow-up questionnaire 12\u2009months later to investigate the possible differences in the prognosis between the phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Two clusters were found. The cluster A included 608 patients (62.4% of the population) and the cluster B 367 patients (37.6%). The three most important variables to separate the clusters were the number of the triggers of cough (mean 2.63 (SD 2.22) vs. 6.95 (2.30), respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001), the number of the cough background disorders (chronic rhinosinusitis, current asthma, gastroesophageal reflux disease, 0.29 (0.50) vs. 1.28 (0.75), respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001), and the Leicester Cough Questionnaire physical domain (5.33 (0.76) vs. 4.25 (0.84), respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001). There were significant interrelationships between these three variables (each\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001). Duration of the episode was not among the most important variables to separate the clusters. At 12\u2009months, 27.0% of the patients of the cluster A and 46.1% of the patients of the cluster B suffered from cough that had continued without interruptions from the first survey (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Two cough phenotypes could be identified. Cluster A represents phenotype A, which includes the majority of patients and has a tendency to heal by itself. The authors propose that cluster B represents phenotype TBQ (Triggers, Background disorders, Quality of life impairment). Given the poor prognosis of this phenotype, it urges a prompt and comprehensive clinical evaluation regardless of the duration of the cough episode.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-020-01485-y","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T08:02:32Z","timestamp":1597910552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cluster analysis in 975 patients with current cough identifies a phenotype with several cough triggers, many background disorders, and low quality of life"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3386-3262","authenticated-orcid":false,"given":"Heikki O.","family":"Koskela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas A.","family":"Selander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"L\u00e4tti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/fampra\/cmt033","volume":"30","author":"P Wandell","year":"2013","unstructured":"Wandell P, Carlsson AC, Wettermark B, Lord G, Cars T, Ljunggren G. Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011. Fam Pract. 2013;30:506\u201313.","journal-title":"Fam Pract"},{"key":"1485_CR2","unstructured":"Centers for disease control and prevention, USA. National Ambulatory Medical Care Survey: 2015 Summary Tables. https:\/\/www.cdc.gov\/nchs\/ahcd\/web_tables.htm#2015. Accessed 13 May 2020."},{"key":"1485_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.chest.2017.10.016","volume":"153","author":"RS Irwin","year":"2018","unstructured":"Irwin RS, French CL, Chang AB, Altman KW. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153:196\u2013209.","journal-title":"Chest"},{"issue":"Suppl 1","key":"1485_CR4","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thx.2006.065144","volume":"61","author":"AH Morice","year":"2006","unstructured":"Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax. 2006;61(Suppl 1):i1\u2013i24.","journal-title":"Thorax"},{"issue":"Suppl 4","key":"1485_CR5","first-page":"135","volume":"11","author":"S Kohno","year":"2006","unstructured":"Kohno S, Ishida T, Uchida Y, Kishimoto H, Sasaki H, Shioya T, et al. The Japanese Respiratory Society guidelines for management of cough. Respirology. 2006;11(Suppl 4):135.","journal-title":"Respirology"},{"key":"1485_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4046\/trd.2016.79.1.14","volume":"79","author":"CK Rhee","year":"2016","unstructured":"Rhee CK, Jung JY, Lee SW, Kim J, Park SY, Yoo KH, et al. The Korean cough guideline: recommendation and summary statement. Tuberc Respir Dis (Seoul). 2016;79:14\u201321.","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1485_CR7","doi-asserted-by":"crossref","unstructured":"Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Ribas CD, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020;55:1901136.","DOI":"10.1183\/13993003.01136-2019"},{"key":"1485_CR8","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","volume":"18","author":"SE Wenzel","year":"2012","unstructured":"Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18:716\u201325.","journal-title":"Nat Med"},{"key":"1485_CR9","doi-asserted-by":"crossref","unstructured":"Sidhaye VK, Nishida K, Martinez FJ. Precision medicine in COPD: where are we and where do we need to go? Eur Respir Rev. 2018;27:180022.","DOI":"10.1183\/16000617.0022-2018"},{"key":"1485_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2013.10.010","volume":"35","author":"J Vestbo","year":"2014","unstructured":"Vestbo J. COPD: definition and phenotypes. Clin Chest Med. 2014;35:1\u20136.","journal-title":"Clin Chest Med"},{"key":"1485_CR11","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). https:\/\/goldcopd.org\/. Accessed 13 May 2020."},{"key":"1485_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1109\/RBME.2010.2083647","volume":"3","author":"R Xu","year":"2010","unstructured":"Xu R, Wunsch DC. Clustering algorithms in biomedical research: a review. IEEE Rev Biomed Eng. 2010;3:120\u201354.","journal-title":"IEEE Rev Biomed Eng"},{"key":"1485_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022950","volume":"8","author":"AM L\u00e4tti","year":"2018","unstructured":"L\u00e4tti AM, Pekkanen J, Koskela HO. Defining the risk factors for acute, subacute and chronic cough: a cross-sectional study in a Finnish adult employee population. BMJ Open. 2018;8:e022950.","journal-title":"BMJ Open"},{"key":"1485_CR14","doi-asserted-by":"crossref","unstructured":"Koskela HO, L\u00e4tti AM, Pekkanen J. The impacts of cough: a cross-sectional study in a Finnish adult employee population. ERJ Open Res. 2018;4:00113\u20138.","DOI":"10.1183\/23120541.00113-2018"},{"key":"1485_CR15","unstructured":"National Institute for Health and Welfare. Health Behaviour and Health among the Finnish Adult Population. https:\/\/thl.fi\/en\/tutkimus-ja-kehittaminen\/tutkimukset-ja-hankkeet\/aikuisten-terveys-hyvinvointi-ja-palvelututkimus-ath\/aiemmat-tutkimukset\/suomalaisen-aikuisvaeston-terveyskayttaytyminen-ja-terveys-avtk. Accessed 13 May 2020."},{"key":"1485_CR16","unstructured":"National Institute for Health and Welfare. The National FINRISK Study. https:\/\/thl.fi\/en\/web\/thlfi-en\/research-and-expertwork\/population-studies\/the-national-finrisk-study. Accessed 13 May 2020."},{"key":"1485_CR17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2045-7022-4-24","volume":"4","author":"A Sa-Sousa","year":"2014","unstructured":"Sa-Sousa A, Jacinto T, Azevedo LF, Morais-Almeida M, Robalo-Cordeiro C, Bugalho-Almeida A, et al. Operational definitions of asthma in recent epidemiological studies are inconsistent. Clin Transl Allergy. 2014;4:24.","journal-title":"Clin Transl Allergy"},{"key":"1485_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhino50E2","volume":"50","author":"WJ Fokkens","year":"2012","unstructured":"Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on Rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;50:1\u2013298.","journal-title":"Rhinol Suppl"},{"key":"1485_CR19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871\u201380.","journal-title":"Gut"},{"key":"1485_CR20","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke K, Spitzer RL, Williams JB. The patient health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284\u201392.","journal-title":"Med Care"},{"key":"1485_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/thorax.58.4.339","volume":"58","author":"SS Birring","year":"2003","unstructured":"Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax. 2003;58:339\u201343.","journal-title":"Thorax"},{"key":"1485_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1745-9974-9-5","volume":"9","author":"E Ternesten-Hass\u00e9us","year":"2013","unstructured":"Ternesten-Hass\u00e9us E, Larsson C, Larsson S, Millqvist E. Capsaicin sensitivity in patients with chronic cough- results from a cross-sectional study. Cough. 2013;9:5.","journal-title":"Cough"},{"key":"1485_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.pupt.2011.01.012","volume":"24","author":"KF Chung","year":"2011","unstructured":"Chung KF. Chronic 'cough hypersensitivity syndrome': a more precise label for chronic cough. Pulm Pharmacol Ther. 2011;24:267\u201371.","journal-title":"Pulm Pharmacol Ther"},{"key":"1485_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00408-010-9272-1","volume":"189","author":"AH Morice","year":"2011","unstructured":"Morice AH, Faruqi S, Wright CE, Thompson R, Bland JM. Cough hypersensitivity syndrome: a distinct clinical entity. Lung. 2011;189:73\u20139.","journal-title":"Lung"},{"key":"1485_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12890-017-0496-1","volume":"17","author":"HO Koskela","year":"2017","unstructured":"Koskela HO, Latti AM, Purokivi MK. Long-term prognosis of chronic cough: a prospective, observational cohort study. BMC Pulm Med. 2017;17:146.","journal-title":"BMC Pulm Med"},{"key":"1485_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030945","volume":"9","author":"HO Koskela","year":"2019","unstructured":"Koskela HO, L\u00e4tti AM, Pekkanen J. Risk factors for repetitive doctor's consultations due to cough: a cross-sectional study in a Finnish employed population. BMJ Open. 2019;9:e030945.","journal-title":"BMJ Open"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01485-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01485-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T19:26:50Z","timestamp":1629401210000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01485-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01485-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28754\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-28754\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"assertion":[{"value":"13 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Kuopio University Hospital (289\/2015). Permission to conduct the study was obtained from officials of the towns. The invitation mail requesting participation in the study included detailed information about the study. The decision of the subject to reply was considered as an informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HK reports grants from Kuopion Seudun Hengityss\u00e4\u00e4ti\u00f6 Foundation and from Hengityssairauksien Tutkimuss\u00e4\u00e4ti\u00f6, during the conduct of the study; personal fees from Mundipharma Ltd., Orion Pharma Ltd., Oy, Eli Lilly Finland Ltd., Boehringer Ingelheim Finland Ltd., MSD Finland Ltd., as payments for giving scientific lectures in gatherings organized by medical companies, personal fees from Takeda Leiras Ltd., Boehringer Ingelheim Ltd., Mundipharma Ltd., and AstraZeneca Ltd., to visit international scientific meetings, and owning shares of Orion Pharma Ltd. worth 30 000 euros.TS reports owning shares of Orion Pharma Ltd. and Novo Nordisk worth 6000 euros.AL reports grants from Kuopion Seudun Hengityss\u00e4\u00e4ti\u00f6 Foundation, grants from Hengityssairauksien Tutkimuss\u00e4\u00e4ti\u00f6, during the conduct of the study; personal fees from Orion, Boehringer-Ingelheim, Roche to visit international scientific meetings.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"219"}}